Cold Spring Harbor Laboratory: New Hope in the Fight Against Neurofibromatosis
March 19, 2024
March 19, 2024
COLD SPRING HARBOR, New York, March 19 -- The Cold Spring Harbor Laboratory issued the following news:
It's the most common single-gene neurological disorder in the world. It is typically diagnosed in children. It's often accompanied by learning challenges. It can lead to tumors in the brain, spinal cord, and throughout the body. It's called neurofibromatosis type 1 (NF1). One out of every 3,000 people is born with the disease. And there is no known cure. Despite all this, research . . .
It's the most common single-gene neurological disorder in the world. It is typically diagnosed in children. It's often accompanied by learning challenges. It can lead to tumors in the brain, spinal cord, and throughout the body. It's called neurofibromatosis type 1 (NF1). One out of every 3,000 people is born with the disease. And there is no known cure. Despite all this, research . . .